Info

Endovasc, Inc. is a business development company that provides long-term debt and equity investment capital to its portfolio companies. The Company's investment portfolio consists primarily of loans with equity features and equity investments in companies, which constitutes a controlling equity interest, and debt obligations. As of June 30, 2006, Endovasc, Inc. had investments in five portfolio companies, Liprostin, Inc., Nutraceutical Development Corporation (NDC), Endovasc-TissueGen Research Sponsors, L.L.C., Endovasc-TissueGen-Blumberg Research Sponsors, L.L.C. and Angiogenix Ltd., Inc.(Source: 10-K)